First Trust NYSE Arca Biotechnology Index Fund
247 hedge funds and large institutions have $707M invested in First Trust NYSE Arca Biotechnology Index Fund in 2023 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 59 increasing their positions, 87 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
32% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 87
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
247
Holding in Top 10
1
Calls
$1.72M
Puts
–
Top Buyers
| 1 | +$10.6M | |
| 2 | +$8.72M | |
| 3 | +$4.14M | |
| 4 |
NA
Navellier & Associates
Reno,
Nevada
|
+$3.51M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$2.2M |
Top Sellers
| 1 | -$12M | |
| 2 | -$11.4M | |
| 3 | -$10.9M | |
| 4 |
AAS
Ameritas Advisory Services
Lincoln,
Nebraska
|
-$7.28M |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$2.9M |